|Mr. C. T. Renganathan||MD & Exec. Director||21.48M||N/A||N/A|
|Mr. Mahesh Narayanaswamy||VP of Fin.||N/A||N/A||N/A|
|Dr. Uday R. Bapat||Chief Technical Advisor||N/A||N/A||N/A|
|Mr. Rajesh Shirambekar||Head of Legal, Company Sec. & Compliance Officer||N/A||N/A||N/A|
|Mr. Tushar Joshi||Head of HR||N/A||N/A||N/A|
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic dosage forms, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company operates through Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients segments. It offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic/anti-depressant, anti-thrombotic, anti-anginal, anti-helmentic, anti-convulsant, anti-spasmodic, and anti-cancer. The company also provides generics primarily in the area of immunosuppressant therapy; and finished dosage formulations for various therapies, such as gastro-intestinal, pain management, cardio-vascular, and nephrology primarily under the Lomotil, Lomofen, Naprosyn, Azoran, Aldactone, and Serenace brands. In addition, it offers urology and cosmetic dermatology therapeutic products. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is based in Mumbai, India.
RPG Life Sciences Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.